Status:
RECRUITING
Angiogenic Factors in the Conservative Management of Gestational Hypertension
Lead Sponsor:
Saint Thomas Hospital, Panama
Conditions:
Gestational Hypertension
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in develo...
Eligibility Criteria
Inclusion
- Pregnant women between 24 and 40 weeks of gestation.
- Diagnosis of Gestational Hypertension based on ACOG criteria
- index sFlt-1/PIGF equal or below 33
Exclusion
- Multiple gestation
- Maternal vasculitis
- Previous cesarean section (3 or more)
- Neurological conditions
- Chronic renal disease
- Purpura
- Heart disease
- Index sFlt-1/PIGF of 34 or more
Key Trial Info
Start Date :
June 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06123377
Start Date
June 1 2024
End Date
September 30 2026
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Santo Tomas
Panama City, Provincia de Panamá, Panama, 0834-1439